Matthew Perez , Elise N. Marino , Curtis Bone , Tara Karns-Wright , Jennifer S. Potter
{"title":"词语很重要:个人选择阿片类药物使用障碍药物的医疗记录中的污名化语言","authors":"Matthew Perez , Elise N. Marino , Curtis Bone , Tara Karns-Wright , Jennifer S. Potter","doi":"10.1016/j.drugalcdep.2025.112831","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>There has been a concerted effort to minimize the use of stigmatizing language in healthcare settings; however, its prevalence in health record documentation remains high. This study examined clinicians’ stigmatizing and patients’ self-stigmatizing language in medical records for patients electing medication for opioid use disorder in two settings, office-based opioid treatment and opioid treatment programs.</div></div><div><h3>Methods</h3><div>In this retrospective cohort study, data were extracted from health records for a distributed provider network serving publicly funded patients in Texas. Patients seeking medication treatment for opioid use disorder between December 2020 and November 2021 were included. Using a natural language processing algorithm to review open text fields in the health records, we identified the prevalence of stigmatizing language identified in the National Institute on Drug Abuse’s “Words Matter” tool.</div></div><div><h3>Results</h3><div>The analytic sample included 1391 patients (63.8 % White, 27.5 % Hispanic, 40.5 % female, M<sub>age</sub>= 40.8 years [SD=10.3]). Of the 6099 notes analyzed, 81.1 % (n = 4944) contained stigmatizing language and 7.1 % (n = 430) contained self-stigmatizing language. In multivariate models, stigmatizing language was associated with age, race, rurality, education, income, opioid use, and treatment setting. Self-stigmatizing language was associated with treatment setting.</div></div><div><h3>Conclusions</h3><div>Findings suggest that a patient’s sociodemographic background influences the stigmatizing language their clinicians use while treatment setting influences both provider and self-stigmatizing language. Additional research is needed to explore whether differences in stigmatizing language contributes to differential treatment outcomes seen in different opioid treatment settings<strong>.</strong></div></div>","PeriodicalId":11322,"journal":{"name":"Drug and alcohol dependence","volume":"275 ","pages":"Article 112831"},"PeriodicalIF":3.6000,"publicationDate":"2025-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Words matter: Stigmatizing language in medical records of individuals electing medication for opioid use disorder\",\"authors\":\"Matthew Perez , Elise N. Marino , Curtis Bone , Tara Karns-Wright , Jennifer S. Potter\",\"doi\":\"10.1016/j.drugalcdep.2025.112831\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>There has been a concerted effort to minimize the use of stigmatizing language in healthcare settings; however, its prevalence in health record documentation remains high. This study examined clinicians’ stigmatizing and patients’ self-stigmatizing language in medical records for patients electing medication for opioid use disorder in two settings, office-based opioid treatment and opioid treatment programs.</div></div><div><h3>Methods</h3><div>In this retrospective cohort study, data were extracted from health records for a distributed provider network serving publicly funded patients in Texas. Patients seeking medication treatment for opioid use disorder between December 2020 and November 2021 were included. Using a natural language processing algorithm to review open text fields in the health records, we identified the prevalence of stigmatizing language identified in the National Institute on Drug Abuse’s “Words Matter” tool.</div></div><div><h3>Results</h3><div>The analytic sample included 1391 patients (63.8 % White, 27.5 % Hispanic, 40.5 % female, M<sub>age</sub>= 40.8 years [SD=10.3]). Of the 6099 notes analyzed, 81.1 % (n = 4944) contained stigmatizing language and 7.1 % (n = 430) contained self-stigmatizing language. In multivariate models, stigmatizing language was associated with age, race, rurality, education, income, opioid use, and treatment setting. Self-stigmatizing language was associated with treatment setting.</div></div><div><h3>Conclusions</h3><div>Findings suggest that a patient’s sociodemographic background influences the stigmatizing language their clinicians use while treatment setting influences both provider and self-stigmatizing language. Additional research is needed to explore whether differences in stigmatizing language contributes to differential treatment outcomes seen in different opioid treatment settings<strong>.</strong></div></div>\",\"PeriodicalId\":11322,\"journal\":{\"name\":\"Drug and alcohol dependence\",\"volume\":\"275 \",\"pages\":\"Article 112831\"},\"PeriodicalIF\":3.6000,\"publicationDate\":\"2025-08-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drug and alcohol dependence\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0376871625002844\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug and alcohol dependence","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0376871625002844","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
Words matter: Stigmatizing language in medical records of individuals electing medication for opioid use disorder
Background
There has been a concerted effort to minimize the use of stigmatizing language in healthcare settings; however, its prevalence in health record documentation remains high. This study examined clinicians’ stigmatizing and patients’ self-stigmatizing language in medical records for patients electing medication for opioid use disorder in two settings, office-based opioid treatment and opioid treatment programs.
Methods
In this retrospective cohort study, data were extracted from health records for a distributed provider network serving publicly funded patients in Texas. Patients seeking medication treatment for opioid use disorder between December 2020 and November 2021 were included. Using a natural language processing algorithm to review open text fields in the health records, we identified the prevalence of stigmatizing language identified in the National Institute on Drug Abuse’s “Words Matter” tool.
Results
The analytic sample included 1391 patients (63.8 % White, 27.5 % Hispanic, 40.5 % female, Mage= 40.8 years [SD=10.3]). Of the 6099 notes analyzed, 81.1 % (n = 4944) contained stigmatizing language and 7.1 % (n = 430) contained self-stigmatizing language. In multivariate models, stigmatizing language was associated with age, race, rurality, education, income, opioid use, and treatment setting. Self-stigmatizing language was associated with treatment setting.
Conclusions
Findings suggest that a patient’s sociodemographic background influences the stigmatizing language their clinicians use while treatment setting influences both provider and self-stigmatizing language. Additional research is needed to explore whether differences in stigmatizing language contributes to differential treatment outcomes seen in different opioid treatment settings.
期刊介绍:
Drug and Alcohol Dependence is an international journal devoted to publishing original research, scholarly reviews, commentaries, and policy analyses in the area of drug, alcohol and tobacco use and dependence. Articles range from studies of the chemistry of substances of abuse, their actions at molecular and cellular sites, in vitro and in vivo investigations of their biochemical, pharmacological and behavioural actions, laboratory-based and clinical research in humans, substance abuse treatment and prevention research, and studies employing methods from epidemiology, sociology, and economics.